Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial

INTRODUCTION: This study assessed the efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in insufficiently controlled people with type 2 diabetes. RESEARCH DESIGN AND METHODS: COBALTA (for its acronym in Spanish, COntrol Basal d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open Diabetes Res Care
Main Authors: Perez, Antonio, Carrasco-Sánchez, Francisco Javier, González, Carlos, Seguí-Ripoll, José Miguel, Trescolí, Carlos, Ena, Javier, Borrell, Mireia, Gomez Huelgas, Ricardo
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical care/Education/Nutrition
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488802/
https://ncbi.nlm.nih.gov/pubmed/32928792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2020-001518
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados